中国临床解剖学杂志 ›› 2012, Vol. 30 ›› Issue (4): 412-416.

• 实验研究 • 上一篇    下一篇

L-NAME对人脐静脉内皮细胞VE-cadherin表达的影响

杨宝林1,3, 伍校琼2, 罗明英1,  朱武1, 叶峰1, 刘丽华1, 关莹露1, 蔡维君1   

  1. 中南大学基础医学院  1.组织与胚胎学系, 2.人体解剖学与神经生物学系,  湖南   长沙    410013;
    3.南昌大学基础医学院人体解剖学教研室,  江西   南昌    330006
  • 收稿日期:2011-10-26 出版日期:2012-07-25 发布日期:2012-07-27
  • 通讯作者: 蔡维君,教授,E-mail:wjcai@yahoo.com E-mail:ybl0027@sina.com
  • 作者简介:杨宝林(1977-),男,江西瑞金市人,在读博士,讲师,主要从事侧支血管生长机制及神经损伤与修复研究,Tel:(0731)82650436
  • 基金资助:

    国家自然科学基金(30971532,30771134);教育部博士点基金(20090162110063);湖南省自然科学基金(09JJ5015)

Effects of L-NAME on the expression of VE-cadherin in human umbilical vein endothelial cell

YANG Bao-lin 1,3, WU Xiao-qiong2, LUO Ming-ying1, ZHU Wu1, YE Feng1, LIU Li-hua1, GUAN Ying-lu1, CAI Wei-jun1   

  1. 1. Department of Histology & Embryology, 2. Department of Anatomy & Neurobiology, School of Basic Medicine, Central South University, Changsha 410013,China; 3. Department of Anatomy, School of Basic Medicine, Nanchang University, Nanchang 330006, China
  • Received:2011-10-26 Online:2012-07-25 Published:2012-07-27

摘要:

目的 探讨一氧化氮合酶(NOS)抑制剂N-硝基-L-精氨酸甲酯(L-NAME)对人脐静脉内皮细胞(HUVEC)的eNOS、VE-cadherin蛋白表达的影响。  方法     HUVEC传代培养并用CD31特异性抗体进行鉴定,实验分为对照组、0.1 mmol/L L-NAME组、1.0 mmol/L L-NAME组,运用MTT比色法检测L-NAME对HUVEC细胞活性的影响,并采用免疫荧光细胞化学法或Western blot检测实验各组HUVEC细胞的eNOS、VE-cadherin等蛋白的表达,以观察L-NAME对HUVEC的eNOS蛋白、VE-cadherin蛋白的影响。  结果    95%以上传代后的细胞为CD31免疫阳性细胞。MTT比色法结果显示,随着L-NAME的浓度增加,HUVEC的细胞活力值逐渐减弱。免疫荧光细胞化学或Western blot结果显示,与对照组比较,0.1 mmol/L L-NAME组和1.0 mmol/L L-NAME组 HUVEC中eNOS的表达减弱(P<0.01),并呈剂量依赖性降低;与对照组比较,0.1 mmol/L L-NAME组和1.0 mmol/L L-NAME组 HUVEC中VE-cadherin的表达增强(P<0.01),呈剂量依赖性增加。  结论    L-NAME能抑制HUVEC 的eNOS表达和细胞活性,并影响细胞粘附连接的主要蛋白—VE-cadherin的表达。

关键词: N-硝基-L-精氨酸甲酯, 人脐静脉内皮细胞, 血管内皮钙粘蛋白

Abstract:

Objective    To investigate the effects of N-nitro-L-arginine methyl ester (L-NAME)as a nitric oxide synthase inhibitor on the expression of eNOS and VE-cadherin in human umbilical vein endothelial cell (HUVEC).   Methods   Subculturing HUVECs were identified with specific antibody to CD31. 3 groups (control group, 0.1mmol/L L-NAME group, 1.0 mmol/L L-NAME group) were designed to carry out in this study. The effects of L-NAME on HUVEC activity was assessed with MTT assay. Expression of eNOS and Ve-cadherin protein in HUVEV of all group were detected with immunocytochemistry staining or Western blot. Results   More than 95% subculturing HUVECs were CD31+ cell. MTT assay showed a L-NAME dose-dependent reduction in HUVEC activity when L-NAME was added into medium. The immunofluorescence intensity of eNOS positive staining in 0.1 mmol/L L-NAME group and 1.0mmol/L L-NAME group were obviously decreased as compared with control group(P<0.01). The immunofluorescence intensity and the relative expression of VE-cadherin positive staining in 0.1mmol/L L-NAME group and 1.0 mmol/L L-NAME group were obviously increased as compared with control group(P<0.01).   Conclusions  L-NAME suppresses the expression of eNOS and cell activity, but improves the expression of VE-cadherin in HUVEC.

Key words: N-nitro-L-arginine methyl ester, Human umbilical vein endothelial cell, VE-cadherin

中图分类号: